{"id":38462,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/2010-stock-incentive-plan-msu-aetna-inc.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"2010-stock-incentive-plan-msu-aetna-inc","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/compensation\/2010-stock-incentive-plan-msu-aetna-inc.html","title":{"rendered":"2010 Stock Incentive Plan (MSU) &#8211; Aetna Inc."},"content":{"rendered":"<p>AETNA INC. 2010 STOCK INCENTIVE PLAN    MARKET STOCK UNIT TERMS OF AWARD<br \/>\n<br \/>\nPursuant to its 2010 Stock Incentive Plan (the &#8220;Plan&#8221;), Aetna Inc. (the<br \/>\n&#8220;Company&#8221;) hereby grants Market Stock Units on the terms and conditions<br \/>\nhereinafter set forth. The number of Market Stock Units awarded is included in<br \/>\nthe website of the designated broker, currently UBS Financial Services, Inc.,<br \/>\nand in the Notice of the Market Stock Unit Grant Acknowledgement and Acceptance<br \/>\nForm. All capitalized terms used herein which are not otherwise defined herein<br \/>\nshall have the meaning specified in the Plan. <br \/>\nARTICLE I <br \/>\nDEFINITIONS<\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(a)<\/p>\n<\/td>\n<td>\n<p>&#8220;Affiliate&#8221; means an entity at least a majority of the total voting power of<br \/>\nthe then-outstanding voting securities of which is held, directly or indirectly,<br \/>\nby the Company and\/or one or more other Affiliates.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(b)<\/p>\n<\/td>\n<td width=\"1190\">\n<p>&#8220;Board&#8221; means the Board of Directors of Aetna Inc.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>(c) &#8220;Change in Control&#8221; means the happening of any of the following:<\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(i)<\/p>\n<\/td>\n<td width=\"1142\">\n<p>When any &#8220;person&#8221; as defined in Section 3(a)(9) of the Securities Exchange<br \/>\nAct of 1934, as amended (the &#8220;Exchange Act&#8221;) and as used in Sections 13(d) and<br \/>\n14(d) thereof, including a &#8220;group&#8221; as defined in Section 13(d) of the Exchange<br \/>\nAct but excluding the Company and any Subsidiary thereof and any employee<br \/>\nbenefit plan sponsored or maintained by the Company or any Subsidiary (including<br \/>\nany trustee of such plan acting as trustee), directly or indirectly, becomes the<br \/>\n&#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act, as amended<br \/>\nfrom time to time), of securities of the Company representing 20 percent or more<br \/>\nof the combined voting power of the Company&#8217;s then outstanding securities;<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(ii)<\/p>\n<\/td>\n<td width=\"1142\">\n<p>When, during any period of 24 consecutive months, the individuals who, at the<br \/>\nbeginning of such period, constitute the Board (the &#8220;Incumbent Directors&#8221;) cease<br \/>\nfor any reason other than death to constitute at least a majority thereof,<br \/>\nprovided that a director who was not a director at the beginning of such<br \/>\n24-month period shall be deemed to have satisfied such 24-month requirement (and<br \/>\nbe an Incumbent Director) if such director was elected by, or on the<br \/>\nrecommendation of or with the approval of, at least two-thirds of the directors<br \/>\nwho then qualified as Incumbent Directors either actually (because they were<br \/>\ndirectors at the beginning of such 24-month period) or by prior operation of<br \/>\nthis paragraph (ii); or<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(iii)<\/p>\n<\/td>\n<td width=\"1142\">\n<p>The occurrence of a transaction requiring stockholder approval for the<br \/>\nacquisition of the Company by an entity other than the Company or a Subsidiary<br \/>\nthrough purchase of assets, or by merger, or otherwise.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>1<\/p>\n<hr>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>Notwithstanding the foregoing, in no event shall a &#8220;Change in Control&#8221; be<br \/>\ndeemed to have occurred (i) as a result of the formation of a Holding Company,<br \/>\nor (ii) with respect to Grantee, if Grantee is part of a &#8220;group,&#8221; within the<br \/>\nmeaning of Section 13(d)(3) of the Exchange Act as in effect on the effective<br \/>\ndate, which consummates the Change in Control transaction. In addition, for<br \/>\npurposes of the definition of &#8220;Change in Control&#8221; a person engaged in business<br \/>\nas an underwriter of securities shall not be deemed to be the &#8220;Beneficial Owner&#8221;<br \/>\nof, or to &#8220;beneficially own,&#8221; any securities acquired through such person&#8217;s<br \/>\nparticipation in good faith in a firm commitment underwriting until the<br \/>\nexpiration of forty days after the date of such acquisition.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(d)<\/p>\n<\/td>\n<td>\n<p>&#8220;Committee&#8221; means the Board&#8217;s Committee on Compensation and Organization or<br \/>\nany successor thereto.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(e)<\/p>\n<\/td>\n<td>\n<p>&#8220;Common Stock&#8221; means the Company&#8217;s Common Shares, $.01 par value per share.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(f)<\/p>\n<\/td>\n<td>\n<p>&#8220;Company&#8221; means Aetna Inc.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(g)<\/p>\n<\/td>\n<td>\n<p>&#8220;Effective Date&#8221; means the date of grant of this award of Market Stock Units.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(h)<\/p>\n<\/td>\n<td>\n<p>&#8220;Fair Market Value&#8221; means the closing price of the Common Stock as reported<br \/>\nby the Consolidated Tape of the New York Stock Exchange Listed Shares on the<br \/>\ndate such value is to be determined, or, if no shares were traded on such date,<br \/>\non the next day on which the Common Stock is traded.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(i)<\/p>\n<\/td>\n<td>\n<p>&#8220;Fundamental Corporate Event&#8221; shall mean any stock dividend, extraordinary<br \/>\ncash dividend, recapitalization, reorganization, merger, consolidation,<br \/>\nsplit-up, spin-off, combination, exchange of shares, warrants or rights offering<br \/>\nto purchase Common Stock at a price substantially below fair market value, or<br \/>\nsimilar event.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(j)<\/p>\n<\/td>\n<td>\n<p>&#8220;Grantee&#8221; means the person to whom this award has been granted.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(k)<\/p>\n<\/td>\n<td>\n<p>&#8220;Holding Company&#8221; means an entity that becomes a holding company for the<br \/>\nCompany or its businesses as a part of any reorganization, merger, consolidation<br \/>\nor other transaction, provided that the outstanding shares of common stock of<br \/>\nsuch entity and the combined voting power of the then outstanding voting<br \/>\nsecurities of such entity entitled to vote generally in the election of<br \/>\ndirectors is, immediately after such reorganization, merger, consolidation or<br \/>\nother transaction, beneficially owned, directly or indirectly, by all or<br \/>\nsubstantially all of the individuals and entities who were the beneficial<br \/>\nowners, respectively, of the voting stock outstanding immediately prior to such<br \/>\nreorganization, merger, consolidation or other transaction in substantially the<br \/>\nsame proportions as their ownership, immediately prior to such reorganization,<br \/>\nmerger, consolidation or other transaction, of such outstanding voting stock.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(l)<\/p>\n<\/td>\n<td>\n<p>&#8220;Long Term Disability&#8221; means long-term disability as defined under the terms<br \/>\nof the Company&#8217;s applicable long-term disability plans or policies.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(m)<\/p>\n<\/td>\n<td>\n<p>&#8220;Net Shares&#8221; means the number of shares of Common Stock which will be<br \/>\ndeposited in a brokerage account in the Grantee&#8217;s name at the Company&#8217;s<br \/>\ndesignated broker after shares have been withheld to satisfy applicable tax and<br \/>\nwithholding requirements upon vesting of the Market Stock Units.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>2<\/p>\n<hr>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(n)<\/p>\n<\/td>\n<td>\n<p>&#8220;Performance Period&#8221; means the [ ] month period following the Effective Date.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(o)<\/p>\n<\/td>\n<td>\n<p>&#8220;Market Stock Units&#8221; means the number of units awarded that will convert to a<br \/>\nnumber of shares of Common Stock based on the operation of Article II of this<br \/>\nAgreement, or such other amount as may result by operation of Article III of<br \/>\nthis Agreement.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(p)<\/p>\n<\/td>\n<td>\n<p>&#8220;Plan&#8221; means the Aetna Inc. 2010 Stock Incentive Plan.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(q)<\/p>\n<\/td>\n<td>\n<p>&#8220;Retirement&#8221; means the termination of employment of a Grantee from active<br \/>\nservice with the Company, a Subsidiary or Affiliate provided the Grantee&#8217;s age<br \/>\nand completed years of service total 65 or more points at termination of<br \/>\nemployment.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(r)<\/p>\n<\/td>\n<td>\n<p>&#8220;Section 162(m)&#8221; means Section 162(m) of the Internal Revenue Code of 1986,<br \/>\nas amended, and the regulation issued thereunder, as may be amended from time to<br \/>\ntime.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(s)<\/p>\n<\/td>\n<td>\n<p>&#8220;Section 409A&#8221; means Section 409A of the Internal Revenue Code of 1986, as<br \/>\namended, and the regulation issued thereunder, as may be amended from time to<br \/>\ntime.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(t)<\/p>\n<\/td>\n<td>\n<p>&#8220;Shares of Stock&#8221; or &#8220;Stock&#8221; means the Common Stock.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(u)<\/p>\n<\/td>\n<td>\n<p>&#8220;Subsidiary&#8221; means an entity of which, at the time such subsidiary status is<br \/>\nto be determined, at least 50% of the total combined voting power of all classes<br \/>\nof stock of such entity is held by the Company and\/or one or more other<br \/>\nsubsidiaries.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(v)<\/p>\n<\/td>\n<td>\n<p>&#8220;Successor&#8221; means the legal representative of the estate of a deceased<br \/>\nGrantee or the person or persons who shall acquire the right to the Market Stock<br \/>\nUnits by bequest or inheritance or by reason of the death of the Grantee.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(w)<\/p>\n<\/td>\n<td>\n<p>&#8220;Vest Date&#8221; means the date on which this award of Market Stock Units shall<br \/>\nvest in accordance with the terms of this Agreement and in the Notice of Market<br \/>\nStock Unit Grant.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(x)<\/p>\n<\/td>\n<td>\n<p>&#8220;Vest Date Fair Market Value&#8221; means the average closing price of the Common<br \/>\nStock as reported by the Consolidated Tape of the New York Stock Exchange Listed<br \/>\nShares for the 29 trading days prior to the Vest Date and the Vest Date, or, if<br \/>\nno shares were traded on such Vest Date, for the 30 trading days prior to the<br \/>\nVest Date.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>ARTICLE II <br \/>\nPERFORMANCE PERIOD &amp; AWARD CONVERSION <br \/>\nSubject to the terms of this Agreement, the Market Stock Units will vest, as of<br \/>\nthe Vest Date, in accordance with the terms of the Plan and this Terms of Award<br \/>\nAgreement, or on such earlier date as provided in Article IV. On the Vest Date<br \/>\nthe Grantee shall vest in a number of shares of Common Stock for each vested<br \/>\nMarket Stock Unit based on the formula below, net of applicable taxes and<br \/>\nwithholding. Such Net Shares will be delivered to the Company&#8217;s designated<br \/>\nbroker, in a brokerage account established in the Grantee&#8217;s name after the Vest<br \/>\nDate. To the extent Section 162(m) is applicable to a Grantee, for shares to<br \/>\nvest the Committee must also determine that the performance goal set forth on<br \/>\nExhibit A is met. If the Committee determines that the performance goal is not<br \/>\nmet at the minimum level, as applicable, no shares will vest. <br \/>\n3<\/p>\n<hr>\n<p><\/p>\n<p>The number of shares of Common Stock that each Market Stock Unit will convert<br \/>\nand be awarded to you on the Vest Date, net of applicable taxes, shall be<br \/>\ndetermined in accordance with the following formula: <br \/>\n(Number of Market Stock Units granted) <br \/>\nMultiplied by <br \/>\n((the Vest Date Fair Market Value) divided by (the Grant Date Fair Market<br \/>\nValue)) <br \/>\nUp to a maximum of 1.5 shares of Common Stock per Market Stock Unit. <br \/>\nAny social security calculation or other adjustments discovered after the<br \/>\npayment of Net Shares will be settled in cash, not in Common Stock. <br \/>\nARTICLE III <br \/>\nCAPITAL CHANGES <br \/>\nIn the event that the Committee shall determine that any Fundamental Corporate<br \/>\nEvent affects the Common Stock such that an adjustment is required to preserve,<br \/>\nor to prevent enlargement of, the benefits or potential benefits made available<br \/>\nunder this Plan, then the Committee shall, in such manner as the Committee may<br \/>\ndeem equitable, adjust the number and kind of shares subject to the award of<br \/>\nMarket Stock Units. Additionally, the Committee may make provision for cash<br \/>\npayment to a Grantee or the Successor of the Grantee to the extent permitted<br \/>\nunder Section 409A. However, the number of Market Stock Units shall always be a<br \/>\nwhole number. <br \/>\nARTICLE IV <br \/>\nCHANGE IN CONTROL <br \/>\nNotwithstanding any other provision of this Agreement to the contrary, upon the<br \/>\noccurrence of a Change in Control, the Market Stock Units not previously<br \/>\nforfeited pursuant to this Terms of Award Agreement shall become immediately<br \/>\nvested and convert to a number of shares of Common Stock based on the formula in<br \/>\nArticle II but such formula shall use the Fair Market Value on the date on which<br \/>\nthe Change in Control occurs rather than the Vest Date Fair Market Value. Net<br \/>\nShares will be payable on the Vest Date, provided however, if within the 24<br \/>\nmonth period following the Change in Control the Company terminates Grantee&#8217;s<br \/>\nemployment without cause, the Net Shares will become payable as of such<br \/>\ntermination of employment date. If an award is considered deferred compensation<br \/>\nsubject to Section 409A, the award will vest but the Change in Control will not<br \/>\naccelerate the payment of the Market Stock Units unless the Change in Control<br \/>\nalso meets the definition of change in control set forth in Treasury Regulation<br \/>\nSection 1.409A-3(i)(5).<\/p>\n<p>4<\/p>\n<hr>\n<p>ARTICLE V <br \/>\nTERMINATION OF EMPLOYMENT<\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(a)<\/p>\n<\/td>\n<td>\n<p>Except as provided in (c) below, if, during the Performance Period, Grantee<br \/>\nshall cease to be employed by the Company, its Subsidiaries or Affiliates, for<br \/>\nreason of death, Long-term Disability, Retirement or involuntary termination of<br \/>\nemployment by the Company, the portion of the Market Stock Units that may vest<br \/>\non the Vest Date, if any, shall be calculated in accordance with the following<br \/>\nformula: (i) the number of completed months employed commencing on the first day<br \/>\nof the Performance Period divided by the number of months in the Performance<br \/>\nPeriod; multiplied by (ii) the number of Market Stock Units that otherwise would<br \/>\nhave vested under the term of this Agreement had the Grantee remained actively<br \/>\nemployed through the Vest Date.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(b)<\/p>\n<\/td>\n<td>\n<p>Except as provided in (a) above, any Market Stock Unit not vested as of the<br \/>\ndate Grantee terminates employment shall be forfeited at the time of cessation<br \/>\nof employment; provided, however, that if Grantee&#8217;s employment is terminated by<br \/>\nthe Company other than for cause and Grantee has not previously, or does not<br \/>\nsubsequently, vest to any portion of the Market Stock Unit in accordance with<br \/>\nits terms, then upon the forfeiture of the entire Market Stock Unit, the Company<br \/>\nwill pay Grantee an amount equal to the value of a single share of Common Stock,<br \/>\nwhether or not the forfeited Market Stock Unit related to more than a single<br \/>\nshare of Common Stock, calculated as of the cessation of employment, if<br \/>\nrequested by Grantee, within 30 days of such cessation of employment.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(c)<\/p>\n<\/td>\n<td width=\"1203\">\n<p>No Market Stock Unit will vest after the Company has terminated the<br \/>\nemployment of the Grantee for cause, unless the Committee, in its sole<br \/>\ndiscretion, deems a payment to be warranted under the particular circumstances.<br \/>\nIn addition, the Market Stock Units will not vest if Grantee has willfully<br \/>\nengaged in gross misconduct or other serious impropriety which the Company<br \/>\ndetermines is likely to be damaging or detrimental to the Company, any<br \/>\nSubsidiary or Affiliate.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(d)<\/p>\n<\/td>\n<td width=\"1204\">\n<p>Employment for purposes of determining the vesting rights of the Grantee and<br \/>\nthe expiration of the grant under this Article V shall mean continuous active<br \/>\nfull-time salaried employment with the Company, a Subsidiary or an Affiliate,<br \/>\nexcept that the period during which the Grantee is on vacation, sick leave, or<br \/>\nother pre-approved leave of absence (provided there is no actual termination of<br \/>\nemployment), shall not interrupt the continuous employment of the Grantee.<br \/>\nEmployment shall also include service with Aetna Foundation, Inc.<br \/>\nNotwithstanding any period during which Grantee receives salary continuation or<br \/>\nseverance shall not be considered as part of the continuous employment of the<br \/>\nGrantee.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>ARTICLE VI <br \/>\nEMPLOYEE COVENANTS<\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(a)<\/p>\n<\/td>\n<td>\n<p>As consideration for this grant of Market Stock Units, without prior written<br \/>\nconsent of the Company:<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"3%\"><\/td>\n<td width=\"3%\" valign=\"top\">\n<p>(i)<\/p>\n<\/td>\n<td width=\"94%\">\n<p>Grantee will not (except to the extent required by an order of a court having<br \/>\ncompetent jurisdiction or under subpoena from an appropriate government agency)<br \/>\nuse or disclose to any third person, whether during or subsequent to Grantee&#8217;s<br \/>\nemployment, any trade secrets, confidential information and proprietary<br \/>\nmaterials, which may include, but are not limited to, the following categories<br \/>\nof information and materials: customer lists and identities; provider lists and<br \/>\nidentities; employee lists and identities; product development and related<br \/>\ninformation; marketing plans and related<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>5<\/p>\n<hr>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>information; sales plans and related information; premium or other pricing<br \/>\ninformation; operating policies and manuals; research; payment rates;<br \/>\nmethodologies; procedures; contractual forms; business plans; financial records;<br \/>\ncomputer programs; database; or other financial, commercial, business or<br \/>\ntechnical information related to the Company or any Subsidiary or Affiliate<br \/>\nunless such information has been previously disclosed to the public by the<br \/>\nCompany or has become public knowledge other than by a breach of this Agreement;<br \/>\nprovided, however, that this limitation shall not apply to any such use or<br \/>\ndisclosure made while Grantee is employed by the Company, any Subsidiary or<br \/>\nAffiliate if such disclosure occurred in connection with the performance of<br \/>\nGrantee&#8217;s job as an employee of the Company, any Subsidiary or Affiliate;<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(ii)<\/p>\n<\/td>\n<td>\n<p>Grantee will not, during and for a period of 12 months or 24 months for<br \/>\nexecutive tier employees (the executive tier status determined as of the<br \/>\neffective date of this grant) following Grantee&#8217;s termination of Employment,<br \/>\ndirectly or indirectly induce or attempt to induce any employee to be employed<br \/>\nor perform services elsewhere;<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(iii)<\/p>\n<\/td>\n<td>\n<p>Grantee will not, during and for a period of 12 months or 24 months for<br \/>\nexecutive tier employees (the executive tier status determined as of the<br \/>\neffective date of this grant) following Grantee&#8217;s termination of Employment,<br \/>\ndirectly or indirectly, induce or attempt to induce any agent or agency, broker,<br \/>\nsupplier or health care provider of the Company or any Subsidiary to cease or<br \/>\ncurtail providing services to the Company or any Subsidiary; and<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(iv)<\/p>\n<\/td>\n<td>\n<p>Grantee will not, during and for a period of 12 months or 24 months for<br \/>\nexecutive tier employees (the executive tier status determined as of the<br \/>\neffective date of this grant) following Grantee&#8217;s termination of Employment,<br \/>\ndirectly or indirectly solicit or attempt to solicit the trade of any individual<br \/>\nor entity which, at the time of such solicitation, is a customer of the Company,<br \/>\nany Subsidiary or Affiliate, or which the Company, any Subsidiary or Affiliate<br \/>\nis undertaking reasonable steps to procure as a customer at the time of or<br \/>\nimmediately preceding termination of Employment; provided, however, that this<br \/>\nlimitation shall only apply to any product or service which is in competition<br \/>\nwith a product or service of the Company, any Subsidiary or Affiliate and shall<br \/>\napply only with respect to a customer or prospective customer with whom the<br \/>\nGrantee has been directly or indirectly involved.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td width=\"1204\">\n<p>In addition:<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(v) (vi)<\/p>\n<\/td>\n<td width=\"1131\">\n<p>Following the termination of Grantee&#8217;s Employment, Grantee shall provide<br \/>\nassistance to and shall cooperate with the Company or a Subsidiary or Affiliate,<br \/>\nupon its reasonable request and without additional compensation, with respect to<br \/>\nmatters within the scope of Grantee&#8217;s duties and responsibilities during<br \/>\nEmployment, provided that any reasonable out-of-pocket expenses Grantee incurs<br \/>\nin connection with any assistance Grantee has been requested to provide under<br \/>\nthis provision for items including, but not limited to, transportation, meals,<br \/>\nlodging and telephone, shall be reimbursed by the Company. The Company agrees<br \/>\nand acknowledges that it shall, to the maximum extent possible under the then<br \/>\nprevailing circumstances, coordinate, or cause a Subsidiary or Affiliate to<br \/>\ncoordinate, any such request with Grantee&#8217;s other commitments and<br \/>\nresponsibilities to minimize the degree to which such request interferes with<br \/>\nsuch commitments and responsibilities; and Grantee shall promptly notify the<br \/>\nCompany&#8217;s General Counsel if Grantee is contacted by a regulatory or<br \/>\nself-regulatory agency with respect to matters pertaining to the Company or by<br \/>\nan<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>6<\/p>\n<hr>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td width=\"1133\">\n<p>attorney or other individual who informs the Grantee that he\/she has filed,<br \/>\nintends to file, or is considering filing a claim or complaint against the<br \/>\nCompany.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(vii)<\/p>\n<\/td>\n<td width=\"1132\">\n<p>Grantee acknowledges that all original works of authorship that are created<br \/>\nby Grantee (solely or jointly with others) within the scope of Grantee&#8217;s<br \/>\nemployment which are protectable by copyright are &#8220;works made for hire&#8221; as that<br \/>\nterm is defined in the United States Copyright Act (17 U.S.C., Section 101).<br \/>\nGrantee further acknowledges that while employed by the Company, Grantee may<br \/>\ndevelop ideas, inventions, discoveries, innovations, procedures, methods,<br \/>\nknow-how or other works which relate to the Company&#8217;s current or are reasonably<br \/>\nexpected to relate to the Company&#8217;s future business that may be patentable or<br \/>\nsubject to trade secret protection. Grantee agrees that all such works of<br \/>\nauthorship, ideas, inventions, discoveries, innovations, procedures, methods,<br \/>\nknow-how and other works shall belong exclusively to the Company, and the<br \/>\nGrantee hereby assigns all right, title, and interest therein to the Company. To<br \/>\nthe extent any of the foregoing works may be patentable, Grantee agrees that the<br \/>\nCompany may file and prosecute any application for patents for such works and<br \/>\nthat the Grantee will, on request, execute assignments to the Company relating<br \/>\nto (and take all such further steps as may be reasonably necessary to perfect<br \/>\nthe Company&#8217;s sole and exclusive ownership of) any such application and any<br \/>\npatents resulting therefrom.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(b)<\/p>\n<\/td>\n<td width=\"1199\">\n<p>If any provision of Article VI (a) is determined by a court of competent<br \/>\njurisdiction not to be enforceable in the manner set forth herein, the Company<br \/>\nand Grantee agree that it is the intention of the parties that such provision<br \/>\nshould be enforceable to the maximum extent possible under applicable law and<br \/>\nthat such court shall reform such provision to make it enforceable in accordance<br \/>\nwith the intent of the parties.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(c)<\/p>\n<\/td>\n<td width=\"1199\">\n<p>Grantee acknowledges that a material part of the inducement for the Company<br \/>\nto grant the Market Stock Units is Grantee&#8217;s covenants set forth in Article VI<br \/>\n(a) and that the covenants and obligations of Grantee with respect to<br \/>\nnondisclosure, non-solicitation and cooperation relate to special, unique and<br \/>\nextraordinary matters and that a violation of any of the terms of such covenants<br \/>\nand obligations will cause the Company irreparable injury for which adequate<br \/>\nremedies are not available at law. Therefore, Grantee agrees that, if Grantee<br \/>\nshall breach any of those covenants or obligations, Grantee shall not be<br \/>\nentitled to vest in the Market Stock or be entitled to retain any income<br \/>\ntherefrom and the Company shall be entitled to an injunction, restraining order<br \/>\nor such other equitable relief (without the requirement to post bond)<br \/>\nrestraining Grantee from committing any violation of the covenants and<br \/>\nobligations contained in Article VI. The Company also shall be entitled to<br \/>\nrecover any attorneys&#8217; fees, costs, and expenses it incurs in connection with<br \/>\nany judicial proceeding arising out of Grantee&#8217;s breach of this Agreement. The<br \/>\nremedies in the preceding sentences are cumulative and are in addition to any<br \/>\nother rights and remedies the Company may have at law or in equity as a court or<br \/>\narbitrator shall reasonably determine.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(d)<\/p>\n<\/td>\n<td>\n<p>Employment Dispute Arbitration Program &#8211; Mandatory Binding Arbitration of<br \/>\nEmployment Disputes.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(i)<\/p>\n<\/td>\n<td width=\"1168\">\n<p>Except as otherwise specified in this Agreement, the Grantee and the Company<br \/>\nagree that all employment-related legal disputes between them will be submitted<br \/>\nto and resolved by binding arbitration, and neither the Grantee nor the Company<br \/>\nwill file or participate as an individual party or member of a class in a<br \/>\nlawsuit in any court against the other with respect to such matters. This shall<br \/>\napply to claims brought on or after the date the Grantee accepts this Agreement,<br \/>\neven if the facts and circumstances relating to the claim occurred prior to that<br \/>\ndate and regardless of whether the Grantee or the Company previously filed a<br \/>\ncomplaint\/charge with a government agency concerning the claim.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>7<\/p>\n<hr>\n<p>For purposes of Article VI (d) of this Agreement, &#8220;the Company&#8221; includes<br \/>\nAetna Inc., its Subsidiaries and Affiliates, their predecessors, successors and<br \/>\nassigns, and those acting as representatives or agents of those entities. THE<br \/>\nGRANTEE UNDERSTANDS THAT, WITH RESPECT TO CLAIMS SUBJECT TO THE ARBITRATION<br \/>\nREQUIREMENT, ARBITRATION REPLACES THE RIGHT OF THE GRANTEE AND THE COMPANY TO<br \/>\nSUE OR PARTICIPATE IN A LAWSUIT. THE GRANTEE ALSO UNDERSTANDS THAT IN<br \/>\nARBITRATION, A DISPUTE IS RESOLVED BY AN ARBITRATOR INSTEAD OF A JUDGE OR JURY,<br \/>\nAND THE DECISION OF THE ARBITRATOR IS FINAL AND BINDING.<\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(ii)<\/p>\n<\/td>\n<td>\n<p>THE GRANTEE UNDERSTANDS THAT THE ARBITRATION PROVISIONS OF THIS AGREEMENT<br \/>\nAFFECT THE LEGAL RIGHTS OF THE GRANTEE AND THE COMPANY AND ACKNOWLEDGES THAT THE<br \/>\nGRANTEE HAS BEEN ADVISED TO, AND HAS BEEN GIVEN THE OPPORTUNITY TO, OBTAIN LEGAL<br \/>\nADVICE BEFORE SIGNING THIS AGREEMENT.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(iii)<\/p>\n<\/td>\n<td>\n<p>Article VI (d) of this Agreement does not apply to workers&#8217; compensation<br \/>\nclaims, unemployment compensation claims, and claims under the Employee<br \/>\nRetirement Income Security Act of 1974 (&#8220;ERISA&#8221;) for employee benefits. A<br \/>\ndispute as to whether Article VI (d) of this Agreement applies must be submitted<br \/>\nto the binding arbitration process set forth in this Agreement.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(iv)<\/p>\n<\/td>\n<td>\n<p>The Grantee and\/or the Company may seek emergency or temporary injunctive<br \/>\nrelief from a court (including with respect to claims arising out of Article VI<br \/>\n(a) in accordance with applicable law). However, except as provided in Article<br \/>\nVI (c) of this Agreement, after the court has issued a ruling concerning the<br \/>\nemergency or temporary injunctive relief, the Grantee and the Company shall be<br \/>\nrequired to submit the dispute to binding arbitration pursuant to this<br \/>\nAgreement.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(v)<\/p>\n<\/td>\n<td>\n<p>Unless otherwise agreed, the arbitration will be administered by the American<br \/>\nArbitration Association (the &#8220;AAA&#8221;) and will be conducted pursuant to the AAA&#8217;s<br \/>\nEmployment Arbitration Rules and Mediation Procedures (the &#8220;Rules&#8221;), as modified<br \/>\nin this Agreement, in effect at the time the request for arbitration is filed.<br \/>\nThe AAA&#8217;s Rules are available on the AAA&#8217;s website at www.adr.org. THE GRANTEE<br \/>\nACKNOWLEDGES THAT THE COMPANY HAS ENCOURAGED THE GRANTEE TO READ THESE RULES<br \/>\nPROMPTLY AND CAREFULLY AND THAT THE GRANTEE HAS BEEN AFFORDED SUFFICIENT<br \/>\nOPPORTUNITY TO DO SO.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(vi)<\/p>\n<\/td>\n<td width=\"1166\">\n<p>If the Company initiates a request for arbitration, the Company will pay all<br \/>\nof the administrative fees and costs charged by the AAA, including the<br \/>\narbitrator&#8217;s compensation and charges for hearing room rentals, etc. If the<br \/>\nGrantee initiates a request for arbitration or submits a counterclaim to the<br \/>\nCompany&#8217;s request for arbitration, the Grantee shall be required to contribute<br \/>\nOne Hundred Dollars ($100.00) to those administrative fees and costs, payable to<br \/>\nthe AAA at the time the Grantee&#8217;s request for arbitration or counterclaim is<br \/>\nsubmitted. The Company may increase the contribution amount in the future<br \/>\nwithout amending this Agreement, but not to exceed the maximum permitted under<br \/>\nthe AAA rules then in effect. In all cases, the Grantee and the Company shall be<br \/>\nresponsible for payment of any fees assessed by the arbitrator as a result of<br \/>\nthat party&#8217;s delay, request for postponement, failure to comply with the<br \/>\narbitrator&#8217;s rulings and for other similar reasons.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(vii)<\/p>\n<\/td>\n<td>\n<p>The Grantee and the Company may choose to be represented by legal counsel in<br \/>\nthe arbitration process and shall be responsible for their own legal fees,<br \/>\nexpenses and costs. However, the<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>8<\/p>\n<hr>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>arbitrator shall have the same authority as a court to order the Grantee or<br \/>\nthe Company to pay some or all of the other&#8217;s legal fees, expenses and costs, in<br \/>\naccordance with applicable law.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(viii)<\/p>\n<\/td>\n<td>\n<p>Unless otherwise agreed, there shall be a single arbitrator, selected by the<br \/>\nGrantee and the Company from a list of qualified neutrals furnished by the AAA.<br \/>\nIf the Grantee and the Company cannot agree on an arbitrator, one will be<br \/>\nselected by the AAA.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(ix)<\/p>\n<\/td>\n<td>\n<p>Unless otherwise agreed, the arbitration hearing will take place in the city<br \/>\nwhere the Grantee works or last worked for the Company. If the Grantee and the<br \/>\nCompany disagree as to the proper locale, the AAA will decide.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(x)<\/p>\n<\/td>\n<td>\n<p>The Grantee and the Company shall be entitled to conduct limited pre-hearing<br \/>\ndiscovery. Each may take the deposition of one person and anyone designated by<br \/>\nthe other as an expert witness. The party taking the deposition shall be<br \/>\nresponsible for all associated costs, such as the cost of a court reporter and<br \/>\nthe cost of an original transcript. Each party also has the right to submit one<br \/>\nset of ten written questions (including subparts) to the other party, which must<br \/>\nbe answered under oath, and to request and obtain all documents on which the<br \/>\nother party relies in support of its answers to the written questions.<br \/>\nAdditional discovery may be permitted by the arbitrator upon a showing that it<br \/>\nis necessary for that party to have a fair opportunity to present a claim or<br \/>\ndefense.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(xi)<\/p>\n<\/td>\n<td>\n<p>The arbitrator shall apply the same substantive law that would apply if the<br \/>\nmatter were heard by a court and shall have the authority to order the same<br \/>\nremedies (but no others) as would be available in a court proceeding. The time<br \/>\nlimits for requesting arbitration or submitting a counterclaim and the<br \/>\nadministrative prerequisites for filing an arbitration claim or counterclaim are<br \/>\nthe same as they would be in a court proceeding. The arbitrator shall consider<br \/>\nand decide any dispositive motions (motions seeking a decision on some or all of<br \/>\nthe claims or counterclaims without an arbitration hearing) filed by any party.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(xii)<\/p>\n<\/td>\n<td>\n<p>All proceedings, including the arbitration hearing and decision, are private<br \/>\nand confidential, unless otherwise required by law. Arbitration decisions may<br \/>\nnot be published or publicized without the consent of both the Grantee and the<br \/>\nCompany.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(xiii)<\/p>\n<\/td>\n<td>\n<p>Unless otherwise agreed, the arbitrator&#8217;s decision will be in writing with a<br \/>\nbrief summary of the arbitrator&#8217;s opinion.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(xiv)<\/p>\n<\/td>\n<td>\n<p>The arbitrator&#8217;s decision is final and binding on the Grantee and the<br \/>\nCompany. After the arbitrator&#8217;s decision is issued, the Grantee or the Company<br \/>\nmay obtain an order of judgment from a court and may obtain a court order<br \/>\nenforcing the decision. The arbitrator&#8217;s decision may be appealed to the courts<br \/>\nonly under the limited circumstances provided by law.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(xv)<\/p>\n<\/td>\n<td>\n<p>If the Grantee previously signed an agreement, including but not limited to<br \/>\nan employment agreement, containing arbitration provisions, those provisions are<br \/>\nsuperseded by the arbitration provisions of this Agreement.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(xvi)<\/p>\n<\/td>\n<td>\n<p>If any provision of Article VI (d) is found to be void or otherwise<br \/>\nunenforceable, in whole or in part, this shall not affect the validity of the<br \/>\nremainder of Article VI (d) and the remainder of the Agreement. All other<br \/>\nprovisions shall remain in full force and effect.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>9<\/p>\n<hr>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(e)<\/p>\n<\/td>\n<td>\n<p>Except as provided in connection with mandatory binding arbitration of<br \/>\nemployment disputes, Grantee hereby submits to the exclusive jurisdiction of the<br \/>\ncourts of the State of Connecticut and the United States District Court for the<br \/>\nDistrict of Connecticut with respect to any action relating to this Agreement,<br \/>\nand agrees that (i) the sole and exclusive appropriate venue for any suit or<br \/>\nproceeding relating to this Agreement shall be in such court, and (ii) hereby<br \/>\nwaives any and all objections and defenses based on forum, venue or personal or<br \/>\nsubject matter jurisdiction as they may relate to a suit or proceeding brought<br \/>\nbefore such court in accordance with the Agreement.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>For purposes of this Article VI, the term &#8220;Employment&#8221; shall refer to active<br \/>\nemployment with the Company, any Subsidiary or Affiliate, and shall not include<br \/>\nsalary continuation or severance periods.<\/p>\n<p>ARTICLE VII <br \/>\nOTHER TERMS<\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(a)<\/p>\n<\/td>\n<td>\n<p>Nothing in this Agreement shall interfere with or limit in any way the right<br \/>\nof the Company or any Subsidiary or Affiliate to terminate the Grantee&#8217;s<br \/>\nemployment at any time. Neither the execution and delivery hereof nor the<br \/>\ngranting of the Award shall constitute or be evidence of any agreement or<br \/>\nunderstanding, express or implied, on the part of the Company or any of its<br \/>\nSubsidiaries to employ or continue the employment of the Grantee for any period.\n<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(b)<\/p>\n<\/td>\n<td>\n<p>Until the Market Stock Units have become vested, Grantee shall not have any<br \/>\nrights as a stockholder (including the right to payment of dividends) by virtue<br \/>\nof this grant of Market Stock Units.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(c)<\/p>\n<\/td>\n<td>\n<p>During the Performance Period, the Market Stock Units shall be<br \/>\nnontransferable and non-assignable except by will or the laws of descent and<br \/>\ndistribution.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(d)<\/p>\n<\/td>\n<td>\n<p>The award, when vested, will be settled on a net basis. Prior to issuing any<br \/>\nCommon Shares, the Company will withhold an amount sufficient to satisfy<br \/>\nfederal, state, local, social security and Medicare withholding tax requirements<br \/>\nrelating to award. Any social security calculation or other adjustments<br \/>\ndiscovered after net share payment will be settled in cash, not in Shares of<br \/>\nCommon Stock. Vesting will result in taxable compensation reportable on the<br \/>\nGrantee&#8217;s W-2 in year of vesting.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(e)<\/p>\n<\/td>\n<td>\n<p>The Company may from time to time adopt stock ownership requirements<br \/>\napplicable to Grantees who are senior managers of the Company. In connection<br \/>\nwith and for the purpose of implementing those ownership requirements, the<br \/>\nCompany may adopt certain restrictions on the ability of a Grantee to sell<br \/>\nshares issued under this Agreement when such ownership requirements have not<br \/>\nbeen satisfied. Any such restriction on sale will be communicated generally to<br \/>\naffected Grantees and the restriction may be modified by the Company from time<br \/>\nto time, at its discretion. Neither the Company nor its Board of Directors shall<br \/>\nhave any obligation or liability to a Grantee in connection with any such<br \/>\nrestriction.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(f)<\/p>\n<\/td>\n<td>\n<p>This Market Stock Unit is an unfunded obligation of the Company and nothing<br \/>\nin this Agreement shall be construed to create any claim against particular<br \/>\nassets or require the Company to segregate or otherwise set aside any assets or<br \/>\ncreate any fund to meet its obligations hereunder.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>10<\/p>\n<hr>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(g)<\/p>\n<\/td>\n<td>\n<p>Anything herein to the contrary notwithstanding, a Grantee whose Market Stock<br \/>\nUnits have been forfeited as a result of termination of employment due to U.S.<br \/>\nMilitary Service and who is later re-employed (in a full-time active status)<br \/>\nafter discharge within the time period set in 38 U.S.C. Section 4312 will be<br \/>\neligible to have the forfeited Market Stock Units reinstated as follows: (i) if<br \/>\nsuch Grantee is re-employed during the Performance Period, all forfeited Market<br \/>\nStock Units shall be reinstated; or (ii) if such Grantee is re-employed after<br \/>\nthe Performance Period, a cash payment will be made to the Grantee, minus<br \/>\napplicable taxes, for the value of the forfeited Market Stock Units on the Vest<br \/>\nDate pursuant to procedures established by the Company for this purpose.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(h)<\/p>\n<\/td>\n<td>\n<p>It is the intention of the Company and Grantee that this Agreement not result<br \/>\nin unfavorable tax consequences to Grantee under Section 409A and the Agreement<br \/>\nshall be interpreted as to so comply. Notwithstanding anything to the contrary<br \/>\nherein, the Company and Grantee agree to the provisions set forth below in order<br \/>\nto comply with the requirements of Section 409A.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(i)<\/p>\n<\/td>\n<td>\n<p>If Grantee is a &#8220;specified employee&#8221; (within the meaning of Section 409A)<br \/>\nwith respect to the Company, any non-qualified deferred compensation otherwise<br \/>\npayable to or in respect of Grantee in connection with Grantee&#8217;s termination of<br \/>\nemployment shall be delayed until the earliest date upon which such amounts may<br \/>\nbe paid without being subject to taxation under Section 409A. Any amount, the<br \/>\npayment or benefit of which is delayed by application of the preceding sentence,<br \/>\nshall be paid as soon as possible following the expiration of such period.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(ii)<\/p>\n<\/td>\n<td>\n<p>Unless deferred pursuant to this agreement, all payments shall be paid to<br \/>\nGrantee, to the extent earned, in no event later than the last day of the<br \/>\n&#8220;applicable 2  1\/2 month period,&#8221; as such term is defined in Treasury Regulation<br \/>\nSection 1.409A-1(b)(4)(i)(A) with respect to such payment&#8217;s treatment as a<br \/>\n&#8220;short-term deferral&#8221; for purposes of Section 409A.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td><\/td>\n<td>\n<p>(iii)<\/p>\n<\/td>\n<td>\n<p>The Company and Grantee agree to cooperate in good faith in an effort to<br \/>\ncomply with Section 409A. Under no circumstances shall the Company be<br \/>\nresponsible for any taxes, penalties, interest or other losses or expenses<br \/>\nincurred by the Grantee due to any failure to comply with Section 409A.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(i)<\/p>\n<\/td>\n<td>\n<p>This Agreement is subject to the 2010 Stock Incentive Plan heretofore adopted<br \/>\nby the Company and approved by its shareholders. The terms and provisions of the<br \/>\nPlan (including any subsequent amendments thereto) are hereby incorporated<br \/>\nherein by reference. In the event of a conflict between any term or provision<br \/>\ncontained herein and a term or provision of the Plan, the applicable terms and<br \/>\nprovisions of the Plan will govern and prevail.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<table style=\"font-family: times new roman; font-size: 9pt;\" align=\"center\" width=\"100%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td>\n<p>(j)<\/p>\n<\/td>\n<td>\n<p>At such times and upon such terms and conditions as the Company shall<br \/>\ndetermine, the Company may permit eligible Grantees to elect to defer the<br \/>\ndistribution of an Award otherwise payable to the Grantee under this Agreement<br \/>\nuntil termination of the Grantee&#8217;s Employment or such other date Company shall<br \/>\npermit.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table style=\"font-family: times new roman; font-size: 9pt;\" width=\"100%\" cellpadding=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"4%\">\n<p>(k)<\/p>\n<\/td>\n<td width=\"96%\">\n<p>This Agreement is made under and shall be governed by and construed in<br \/>\naccordance with the laws of the State of Connecticut, without giving effect to<br \/>\nits choice of law provisions.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/p>\n<p>11<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6587],"corporate_contracts_industries":[9440],"corporate_contracts_types":[9539,9546],"class_list":["post-38462","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-aetna-inc","corporate_contracts_industries-health__plans","corporate_contracts_types-compensation","corporate_contracts_types-compensation__incentive"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/38462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=38462"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=38462"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=38462"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=38462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}